Jun 30, 2018

ANI Pharmaceuticals Q2 2018 Earnings Report

Total Revenue
$47.3M
Previous year: $44.8M
+5.6%
EPS
$1.13
Previous year: $0.98
+15.3%
Gross Profit
$30.7M
Previous year: $23.6M
+29.7%
Cash and Equivalents
$55M
Previous year: $8.37M
+557.1%
Free Cash Flow
$7.51M
Previous year: -$2.3M
-426.0%
Total Assets
$424M
Previous year: $359M
+18.1%

ANI Pharmaceuticals

ANI Pharmaceuticals